Iovance Biotherapeutics names Noah Berkowitz chief medical officer
IOVA•Iovance Biotherapeutics appointed Noah Berkowitz chief medical officer, effective Sept. 30, 2026.
1. Berkowitz’s experience
Berkowitz previously served as chief medical officer at Arvinas Pharmaceuticals and as a senior vice president and hematology therapeutic area head at Bristol Myers Squibb, overseeing hematology development and interim cell therapy programs. Earlier, he held clinical development leadership roles at Novartis and completed a medical oncology fellowship at the National Cancer Institute.
